July 2018—Beckman Coulter announced its Early Sepsis Indicator received the CE mark. The Early Sepsis Indicator is a hematology-based solution designed to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis and is to be offered as part of a routine CBC with differential test.
The Early Sepsis Indicator is available on the recently launched DxH 900 hematology analyzer and uses the DxH 900’s Coulter technology, which characterizes cells in their near-native states. The system’s VCS 360 technology detects morphological changes in monocytes, cells of the innate immune system that provide a first line of defense against infections.
Beckman plans to submit a 510(k) for the test in the near future.
Beckman Coulter, 714-993-5321